Technology Development for non-invasive prenatal genetic diagnosis using maternal peripheral blood (H-24326)
Study Goal(s): Development and validation of new methods to diagnose genetic diseases in the fetus by studying cells and fetal DNA in the mother's blood.
Eligibility Criteria: Pregnant women over 18 years old who have prenatal diagnosis by amniocentesis or chorionic villus sampling
Investigators: Ignatia Van den Veyver, M.D. (principal investigator)
Supported by: Baylor College of Medicine
NIH Contact: email@example.com